Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
Nov 1995;45(11):1211-1216
GLP-1 (glucagon-like peptide-1) medications are FDA-approved treatments that mimic a hormone naturally produced in your intestines
Studies using continuous glucose monitoring and peptide assays show that GLP-1 can spike in the 24 hours before a person's typical eating window ends, suggesting an endogenous 'meal-anticipation' signal
To the best of our knowledge, this is the first time to demonstrate that, for MC patients, long time use of anthraquinone laxatives may inhibit P450, particularly CYP3A4, in the intestine
As a board-certified bariatric and weight loss surgeon, Ive worked with thousands of patients struggling with obesity, metabolic disease, and long-term weight management
.webp)
